The Use of Eculizumab in HELLP Syndrome

Clinical trial NCT04103489 · COMPLETED

Trial details

NCT number: NCT04103489
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HELLP Syndrome (HELLP), Third Trimester Complement Abnormality Morbidity;Newborn Maternal Injury Preeclampsia Severe

Start date: 2021-02-23
Primary completion: 2023-08-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.